Biophytis S.A.
BPTSY
$2.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.54M | 5.49M | 5.42M | 5.70M | 5.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.20M | 11.21M | 13.20M | 14.39M | 15.50M |
| Operating Income | -9.20M | -11.21M | -13.20M | -14.39M | -15.50M |
| Income Before Tax | -11.23M | -13.78M | -16.31M | -17.41M | -18.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.23 | -13.78 | -16.31 | -17.41 | -18.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.50K | 6.00K | 5.40K | 2.70K | -- |
| Net Income | -11.23M | -13.78M | -16.31M | -17.41M | -18.41M |
| EBIT | -9.20M | -11.21M | -13.20M | -14.39M | -15.50M |
| EBITDA | -8.93M | -10.86M | -12.77M | -13.89M | -14.93M |
| EPS Basic | -2.51 | -4.79 | -7.08 | -11.35 | -15.53 |
| Normalized Basic EPS | -1.57 | -3.10 | -4.64 | -7.06 | -9.43 |
| EPS Diluted | -2.51 | -4.79 | -7.08 | -11.35 | -15.53 |
| Normalized Diluted EPS | -1.57 | -3.10 | -4.64 | -7.06 | -9.43 |
| Average Basic Shares Outstanding | 20.77M | 15.78M | 10.79M | 8.11M | 5.43M |
| Average Diluted Shares Outstanding | 20.77M | 15.78M | 10.79M | 8.11M | 5.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |